Definitive Healthcare Corp. (NASDAQ:DH) Shares Purchased by Quantbot Technologies LP

Quantbot Technologies LP raised its position in Definitive Healthcare Corp. (NASDAQ:DH) by 5,305.5% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 17,730 shares of the company’s stock after purchasing an additional 17,402 shares during the period. Quantbot Technologies LP’s holdings in Definitive Healthcare were worth $73,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. State Street Corp increased its stake in shares of Definitive Healthcare by 29.4% during the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after purchasing an additional 317,952 shares in the last quarter. 272 Capital LP increased its position in Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock worth $4,980,000 after buying an additional 476,766 shares in the last quarter. New York State Common Retirement Fund raised its holdings in shares of Definitive Healthcare by 3.2% in the fourth quarter. New York State Common Retirement Fund now owns 771,792 shares of the company’s stock worth $3,172,000 after acquiring an additional 23,815 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Definitive Healthcare by 5.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 436,132 shares of the company’s stock valued at $1,950,000 after acquiring an additional 23,706 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Definitive Healthcare by 35.9% during the fourth quarter. Bank of New York Mellon Corp now owns 229,143 shares of the company’s stock valued at $942,000 after acquiring an additional 60,559 shares during the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Performance

Shares of NASDAQ:DH opened at $2.89 on Tuesday. The business has a 50-day moving average of $4.07 and a two-hundred day moving average of $4.25. The firm has a market capitalization of $326.31 million, a PE ratio of -0.93, a P/E/G ratio of 4.06 and a beta of 1.51. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. Definitive Healthcare Corp. has a 12 month low of $2.55 and a 12 month high of $8.35.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). The business had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. As a group, research analysts forecast that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. The Goldman Sachs Group cut their target price on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Stephens started coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price for the company. Finally, Barclays reduced their price target on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Definitive Healthcare has a consensus rating of “Hold” and a consensus price target of $5.35.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.